These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 24846067)

  • 21. Potential Role of microRNAs in inducing Drug Resistance in Patients with Multiple Myeloma.
    Allegra A; Ettari R; Innao V; Bitto A
    Cells; 2021 Feb; 10(2):. PubMed ID: 33672466
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The potential of miRNAs as biomarkers for multiple myeloma.
    Rocci A; Hofmeister CC; Pichiorri F
    Expert Rev Mol Diagn; 2014 Nov; 14(8):947-59. PubMed ID: 25098410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA Transfer Between Bone Marrow Adipose and Multiple Myeloma Cells.
    Soley L; Falank C; Reagan MR
    Curr Osteoporos Rep; 2017 Jun; 15(3):162-170. PubMed ID: 28432594
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miRNAs in multiple myeloma--a survival relevant complex regulator of gene expression.
    Seckinger A; Meißner T; Moreaux J; Benes V; Hillengass J; Castoldi M; Zimmermann J; Ho AD; Jauch A; Goldschmidt H; Klein B; Hose D
    Oncotarget; 2015 Nov; 6(36):39165-83. PubMed ID: 26472281
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA: important player in the pathobiology of multiple myeloma.
    Bi C; Chng WJ
    Biomed Res Int; 2014; 2014():521586. PubMed ID: 24991558
    [TBL] [Abstract][Full Text] [Related]  

  • 26. EZH2 inhibition in multiple myeloma downregulates myeloma associated oncogenes and upregulates microRNAs with potential tumor suppressor functions.
    Alzrigat M; Párraga AA; Agarwal P; Zureigat H; Österborg A; Nahi H; Ma A; Jin J; Nilsson K; Öberg F; Kalushkova A; Jernberg-Wiklund H
    Oncotarget; 2017 Feb; 8(6):10213-10224. PubMed ID: 28052011
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiple Myeloma Bone Disease: Implication of MicroRNAs in Its Molecular Background.
    Papanota AM; Karousi P; Kontos CK; Ntanasis-Stathopoulos I; Scorilas A; Terpos E
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33673480
    [TBL] [Abstract][Full Text] [Related]  

  • 28. microRNAs: Key Players in Hematopoiesis.
    Raghuwanshi S; Karnati HK; Sarvothaman S; Gutti U; Saladi RG; Tummala PR; Gutti RK
    Adv Exp Med Biol; 2015; 887():171-211. PubMed ID: 26662992
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Integrative high-resolution microarray analysis of human myeloma cell lines reveals deregulated miRNA expression associated with allelic imbalances and gene expression profiles.
    Lionetti M; Agnelli L; Mosca L; Fabris S; Andronache A; Todoerti K; Ronchetti D; Deliliers GL; Neri A
    Genes Chromosomes Cancer; 2009 Jun; 48(6):521-31. PubMed ID: 19306352
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Focusing on long non-coding RNA dysregulation in newly diagnosed multiple myeloma.
    Shen Y; Feng Y; Chen H; Huang L; Wang F; Bai J; Yang Y; Wang J; Zhao W; Jia Y; Peng Y; Lei X; He A
    Life Sci; 2018 Mar; 196():133-142. PubMed ID: 29459023
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA and cancer--a brief overview.
    Acunzo M; Romano G; Wernicke D; Croce CM
    Adv Biol Regul; 2015 Jan; 57():1-9. PubMed ID: 25294678
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deregulated microRNAs in multiple myeloma.
    Benetatos L; Vartholomatos G
    Cancer; 2012 Feb; 118(4):878-87. PubMed ID: 21837684
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MiRNome expression is deregulated in the peripheral lymphoid compartment of multiple myeloma.
    Campo S; Allegra A; D'Ascola A; Alonci A; Scuruchi M; Russo S; Avenoso A; Gerace D; Campo GM; Musolino C
    Br J Haematol; 2014 Jun; 165(6):801-13. PubMed ID: 24620752
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potential roles of microRNAs and their target genes in human multiple myeloma.
    Yang Y; Lin J; Ma Z; Li J; Li D; Wang B; Fei Q
    Eur J Haematol; 2017 Aug; 99(2):178-185. PubMed ID: 28467652
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA (miRNA) expression profiling of peripheral blood samples in multiple myeloma patients using microarray.
    Yyusnita ; Norsiah ; Zakiah I; Chang KM; Purushotaman VS; Zubaidah Z; Jamal R
    Malays J Pathol; 2012 Dec; 34(2):133-43. PubMed ID: 23424776
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [MicroRNA Analysis for Extramedullary Multiple Myeloma Relapse].
    Gregorová J; Vrábel D; Radová L; Gablo NA; Almaši M; Štork M; Slabý O; Pour L; Minařík J; Ševčíková S
    Klin Onkol; 2018; 31(Supplementum1):148-150. PubMed ID: 29808690
    [TBL] [Abstract][Full Text] [Related]  

  • 37. miRNAs driving diagnosis, progression, and drug resistance in multiple myeloma.
    Elkady MA; Yehia AM; Elsakka EGE; Abulsoud AI; Abdelmaksoud NM; Elshafei A; Elkhawaga SY; Ismail A; Mokhtar MM; El-Mahdy HA; Hegazy M; Elballal MS; Mohammed OA; El-Husseiny HM; Midan HM; El-Dakroury WA; Zewail MB; Abdel Mageed SS; Doghish AS
    Pathol Res Pract; 2023 Aug; 248():154704. PubMed ID: 37499518
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of Peripheral Blood miRNA-720 and miRNA-1246 Can Be Used as a Predictor for Outcome in Multiple Myeloma Patients.
    Ren Y; Li X; Wang W; He W; Wang J; Wang Y
    Clin Lymphoma Myeloma Leuk; 2017 Jul; 17(7):415-423. PubMed ID: 28601493
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Altered microRNA expression profile in the peripheral lymphoid compartment of multiple myeloma patients with bisphosphonate-induced osteonecrosis of the jaw.
    Musolino C; Oteri G; Allegra A; Mania M; D'Ascola A; Avenoso A; Innao V; Allegra AG; Campo S
    Ann Hematol; 2018 Jul; 97(7):1259-1269. PubMed ID: 29546453
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potential role of exosome-associated microRNA panels and in vivo environment to predict drug resistance for patients with multiple myeloma.
    Zhang L; Pan L; Xiang B; Zhu H; Wu Y; Chen M; Guan P; Zou X; Valencia CA; Dong B; Li J; Xie L; Ma H; Wang F; Dong T; Shuai X; Niu T; Liu T
    Oncotarget; 2016 May; 7(21):30876-91. PubMed ID: 27129167
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.